These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 601957)

  • 1. [Erythrocyte aggregation in diabetic retinopathy].
    Beliaeva MI; Shestakov VA
    Vestn Oftalmol; 1977; (6):57-60. PubMed ID: 601957
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphaden in diabetic retinopathy].
    Mukha AI; Kondé LA; Davydova NG; Begliarova AS; Agranovich MS
    Vestn Oftalmol; 1988; 104(2):47-50. PubMed ID: 3394203
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of abnormal blood rheology in the pathogenesis of diabetic retinopathy.
    Little HL; Sacks AH
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1977; 83(3 Pt 1):OP522-34. PubMed ID: 888262
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rheologic findings in patients with diabetic retinopathy].
    Bertram B; Wolf S; Kaufhold F; Jung F; Kiesewetter H; Reim M
    Fortschr Ophthalmol; 1991; 88(4):321-5. PubMed ID: 1786912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood viscosity factors in nondiabetic and diabetic retinopathy.
    Dintenfass L
    Bibl Anat; 1977; (16 Pt 2):422-4. PubMed ID: 603574
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of aspirin on hemorheological parameters of patients with diabetic retinopathy.
    Vekasi J; Koltai K; Gaal V; Toth A; Juricskay I; Kesmarky G
    Clin Hemorheol Microcirc; 2008; 39(1-4):385-9. PubMed ID: 18503149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythrocyte aggregation in vivo and diabetic microangiopathy. Physiopathologic determinants and clinical correlations].
    Benhamou PY; Carpentier P; Halimi S; Bertrand C; Mouillon M; Franco A
    Diabete Metab; 1990; 16(3):192-8. PubMed ID: 2210013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-proliferative diabetic retinopathy and red blood cell aggregation].
    Turczyński B; Michalska-Małecka K; Słowińska L; Szczesny S; Romaniuk W
    Wiad Lek; 2004; 57(11-12):634-40. PubMed ID: 15865241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorheological alterations in patients with diabetic retinopathy.
    Vekasi J; Marton ZS; Kesmarky G; Cser A; Russai R; Horvath B
    Clin Hemorheol Microcirc; 2001; 24(1):59-64. PubMed ID: 11345235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Red blood cell aggregability in diabetic retinopathy].
    Miyashita K; Tanahashi N; Akiya S
    Nippon Ganka Gakkai Zasshi; 1988 Jul; 92(7):1166-70. PubMed ID: 3189092
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet aggregation and intraplatelet adenine nucleotides in diabetic retinopathy.
    Nozaki H; Hiramatsu K; Arimori S
    Scand J Clin Lab Invest; 1987 Sep; 47(5):441-5. PubMed ID: 3659822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte and thrombocyte aggregation disorders in the pathogenesis of diabetic retinopathy and the potentials of disaggregation therapy].
    Tartakovskaia AI; Arkhangel'skaia EN; Dudnikova LK
    Vestn Oftalmol; 1983; (6):59-62. PubMed ID: 6659243
    [No Abstract]   [Full Text] [Related]  

  • 15. The balance between anemia, erythropoietin treatment, and elevated erythrocyte aggregation in patients with diabetic retinopathy and nephropathy: a hematologic point of view.
    Demiroglu H
    Am J Ophthalmol; 2003 Oct; 136(4):776; author reply 776-7. PubMed ID: 14516841
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of abnormal hemorrheodynamics in the pathogenesis of diabetic retinopathy.
    Little HL
    Trans Am Ophthalmol Soc; 1976; 74():573-636. PubMed ID: 867639
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of rheological factors on diabetic microangiopathies: is there an effective medical treatment for diabetic retinopathy?].
    Meunier I; Soubrane G; Coscas G
    Bull Soc Belge Ophtalmol; 1995; 256():67-70. PubMed ID: 8581233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy.
    Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation in diabetic retinopathy.
    Khosla PK; Mahabaleshwara M; Tewari HK; Saraya AK
    Indian J Ophthalmol; 1981 Oct; 29(3):277-82. PubMed ID: 7346443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.